Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
European Journal of Histochemistry : EJH
|
May 27, 2008
Pavia symposium on embryos and stem cells
M Boiani, N Crosetto, C A Redi
Leukemia
|
August 22, 2003
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
P Bernasconi, P M Cavigliano, M Boni, et al.
Blood Cancer Journal
|
October 11, 2014
Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
A Barreca, C Martinengo, L Annaratone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 3, 2010
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
M Merlano, E Russi, M Benasso, et al.
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
European Journal of Histochemistry : EJH
|
May 27, 2008
Pavia symposium on embryos and stem cells
M Boiani, N Crosetto, C A Redi
Leukemia
|
August 22, 2003
Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
P Bernasconi, P M Cavigliano, M Boni, et al.
Blood Cancer Journal
|
October 11, 2014
Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
A Barreca, C Martinengo, L Annaratone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 3, 2010
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
M Merlano, E Russi, M Benasso, et al.
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Page
of 1